
Results
16
16 companies
D&D Pharmatech
Market Cap: ₩3.2t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩74,000.00
7D
7.9%
1Y
511.6%
Hanmi Pharm
Market Cap: ₩6.3t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩500,000.00
7D
-1.4%
1Y
105.8%
Peptron
Market Cap: ₩6.2t
Engages in the development of peptide-based medicines.
A087010
₩267,500.00
7D
-2.9%
1Y
62.4%
ALTEOGEN
Market Cap: ₩19.3t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩361,500.00
7D
-1.1%
1Y
-3.5%
SK Biopharmaceuticals
Market Cap: ₩7.7t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩98,500.00
7D
4.7%
1Y
-3.5%
Caregen
Market Cap: ₩4.2t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩85,600.00
7D
-20.4%
1Y
219.4%
Samsung BiologicsLtd
Market Cap: ₩72.7t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,571,000.00
7D
1.1%
1Y
-2.2%
OliX Pharmaceuticals
Market Cap: ₩3.3t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩164,800.00
7D
0.5%
1Y
236.0%
PharmaResearch
Market Cap: ₩3.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩302,000.00
7D
4.0%
1Y
-17.5%
ABL Bio
Market Cap: ₩8.8t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩157,700.00
7D
0.6%
1Y
180.6%
ST PharmLtd
Market Cap: ₩3.0t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩143,300.00
7D
3.8%
1Y
88.3%
Celltrion
Market Cap: ₩43.7t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩199,700.00
7D
2.3%
1Y
28.9%
Aimed Bio
Market Cap: ₩3.1t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩47,550.00
7D
-1.6%
1Y
n/a
LigaChem Biosciences
Market Cap: ₩6.9t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩188,200.00
7D
7.5%
1Y
74.4%
Voronoi
Market Cap: ₩5.2t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩287,000.00
7D
2.9%
1Y
147.4%
Yuhan
Market Cap: ₩6.9t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩92,900.00
7D
0.1%
1Y
-15.3%